J H Marco Jansen Selected Research

J H Marco Jansen Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 04/2010
2	Infections 01/2020 - 01/2018
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2018
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Lymphoma (Lymphomas) 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Multiple Myeloma 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Melanoma (Melanoma, Malignant) 08/2014

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 06/2023 - 04/2010
9	Immunoglobulin A (IgA)IBA 09/2023 - 12/2015
8	Immunoglobulin G (IgG)IBA 01/2020 - 08/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
4	Monoclonal AntibodiesIBA 01/2020 - 12/2011
4	Fc Receptors (Fc Receptor)IBA 01/2019 - 04/2010
3	LigandsIBA 06/2023 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 08/2021 - 04/2010
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 06/2023 - 01/2023
2	Sialic AcidsIBA 06/2023 - 01/2023
2	glutaminyl-peptide cyclotransferaseIBA 08/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Palivizumab FDA Link 01/2020 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2019
2	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2015
2	Complement System Proteins (Complement)IBA 01/2019 - 12/2011
1	CollagenIBA 01/2024
1	Fc(alpha) receptorIBA 09/2023
1	SialyltransferasesIBA 01/2023
1	TransferasesIBA 01/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023
1	CaspasesIBA 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	IntegrinsIBA 08/2021
1	Glutamic Acid (Glutamate)FDA Link 08/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	AntigensIBA 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	necitumumabIBA 01/2019
1	motavizumab (Numax)IBA 01/2018
1	daratumumabIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 12/2015
1	Glycoproteins (Glycoprotein)IBA 08/2014
1	ofatumumab FDA Link 12/2011
1	Rituximab (Mabthera)FDA Link 12/2011
1	Complement Receptors (Complement Receptor)IBA 12/2011

Therapy/Procedure

8	Immunotherapy 09/2023 - 04/2010
6	Therapeutics 06/2023 - 01/2016
1	Intranasal Administration 01/2020